- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Biodefense market will register a 7.6% CAGR in terms of revenue, the global market size will reach $ 1294.7 million by 2025, from $ 966.8 million in 2019. In particular, this report presents the global revenue market share of key companies in Biodefense business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Biodefense market by product type, application, key manufacturers and key regions and countries.
Segmentation by product type:
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Segmentation by Application:
US Military Market
US Civilian Market
Non - US Market
This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/players in the market. The key players covered in this report:
Emergent Biosolutions
Xoma Corporation
Hytest
Sanofi
PharmAthene
GSK
Arbutus Biopharma
Bavarian Nordic
DynPort Vaccine
SIGA Technologies
Cleveland BioLabs
Alnylam Pharmaceuticals
Soligenix
Ichor Medical Systems
Elusys Therapeutics
Achaogen
Dynavax Technologies
Aeolus Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biodefense market size by key regions/countries, type and application.
To understand the structure of Biodefense market by identifying its various subsegments.
Focuses on the key global Biodefense players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biodefense with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Biodefense submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biodefense Market Size 2021-2025
2.1.2 Biodefense Market Size CAGR by Region
2.2 Biodefense Segment by Type
2.2.1 Anthrax
2.2.2 Smallpox
2.2.3 Botulism
2.2.4 Radiation/Nuclear
2.2.5 Others
2.3 Biodefense Market Size by Type
2.3.1 Global Biodefense Market Size Market Share by Type (2021-2025)
2.3.2 Global Biodefense Market Size Growth Rate by Type (2021-2025)
2.4 Biodefense Segment by Application
2.4.1 US Military Market
2.4.2 US Civilian Market
2.4.3 Non - US Market
2.5 Biodefense Market Size by Application
2.5.1 Global Biodefense Market Size Market Share by Application (2021-2025)
2.5.2 Global Biodefense Market Size Growth Rate by Application (2021-2025)
3 Biodefense Key Players
3.1 Date of Key Players Enter into Biodefense
3.2 Key Players Biodefense Product Offered
3.3 Key Players Biodefense Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Biodefense Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Biodefense by Regions
4.1 Biodefense Market Size by Regions (2015-2020)
4.2 Americas Biodefense Market Size Growth (2015-2020)
4.3 APAC Biodefense Market Size Growth (2015-2020)
4.4 Europe Biodefense Market Size Growth (2015-2020)
5 Americas
5.1 Americas Biodefense Market Size by Countries (2021-2025)
5.2 Americas Biodefense Market Size by Type (2021-2025)
5.3 Americas Biodefense Market Size by Application (2021-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Biodefense Market Size by Regions
6.2 APAC Biodefense Market Size by Type (2021-2025)
6.3 APAC Biodefense Market Size by Application (2021-2025)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Biodefense by Countries (2021-2025)
7.2 Europe Biodefense Market Size by Type (2021-2025)
7.3 Europe Biodefense Market Size by Application (2021-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles
9 Key Investors in Biodefense
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……
10 Key Players Analysis
10.1 Emergent Biosolutions
10.1.1 Emergent Biosolutions Company Information
10.1.2 Biodefense Product Offered
10.1.3 Emergent Biosolutions Biodefense Market Size (2020 VS 2025)
10.1.4 Main Business Overview
10.1.5 Emergent Biosolutions Latest Developments
10.2 Xoma Corporation
10.2.1 Xoma Corporation Company Information
10.2.2 Biodefense Product Offered
10.2.3 Xoma Corporation Biodefense Market Size (2020 VS 2025)
10.2.4 Main Business Overview
10.2.5 Xoma Corporation Latest Developments
10.3 Hytest
10.3.1 Hytest Company Information
10.3.2 Biodefense Product Offered
10.3.3 Hytest Biodefense Market Size (2020 VS 2025)
10.3.4 Main Business Overview
10.3.5 Hytest Latest Developments
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Biodefense Product Offered
10.4.3 Sanofi Biodefense Market Size (2020 VS 2025)
10.4.4 Main Business Overview
10.4.5 Sanofi Latest Developments
10.5 PharmAthene
10.5.1 PharmAthene Company Information
10.5.2 Biodefense Product Offered
10.5.3 PharmAthene Biodefense Market Size (2020 VS 2025)
10.5.4 Main Business Overview
10.5.5 PharmAthene Latest Developments
10.6 GSK
10.6.1 GSK Company Information
10.6.2 Biodefense Product Offered
10.6.3 GSK Biodefense Market Size (2020 VS 2025)
10.6.4 Main Business Overview
10.6.5 GSK Latest Developments
10.7 Arbutus Biopharma
10.7.1 Arbutus Biopharma Company Information
10.7.2 Biodefense Product Offered
10.7.3 Arbutus Biopharma Biodefense Market Size (2020 VS 2025)
10.7.4 Main Business Overview
10.7.5 Arbutus Biopharma Latest Developments
10.8 Bavarian Nordic
10.8.1 Bavarian Nordic Company Information
10.8.2 Biodefense Product Offered
10.8.3 Bavarian Nordic Biodefense Market Size (2020 VS 2025)
10.8.4 Main Business Overview
10.8.5 Bavarian Nordic Latest Developments
10.9 DynPort Vaccine
10.9.1 DynPort Vaccine Company Information
10.9.2 Biodefense Product Offered
10.9.3 DynPort Vaccine Biodefense Market Size (2020 VS 2025)
10.9.4 Main Business Overview
10.9.5 DynPort Vaccine Latest Developments
10.10 SIGA Technologies
10.10.1 SIGA Technologies Company Information
10.10.2 Biodefense Product Offered
10.10.3 SIGA Technologies Biodefense Market Size (2020 VS 2025)
10.10.4 Main Business Overview
10.10.5 SIGA Technologies Latest Developments
10.11 Cleveland BioLabs
10.12 Alnylam Pharmaceuticals
10.13 Soligenix
10.14 Ichor Medical Systems
10.15 Elusys Therapeutics
10.16 Achaogen
10.17 Dynavax Technologies
10.18 Aeolus Pharmaceuticals
11 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Biodefense Market Size CAGR by Region (2021-2025) ($ Millions)
Table 4. Major Players of Anthrax
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
